The German economy has been widely seen as failing to develop the commercial
innovation competencies necessary to compete in new technologies. Starting in the mid …

Given what institutional scholars have described as an inhospitable institutional climate for
entrepreneurial business, why has the German biotechnology industry suddenly taken off …

The paper explores the influence of institutional frameworks on the evolution of the German
software and biotechnology sectors. It links institutional constraints to poor performance of …

This article examines a decade of federal support for biotechnology in the Federal Republic
of Germany in order to determine the impact of liberal corporatist patterns of decision …

This paper analyzes how governance structures impact the innovation capabilities of
leading German and UK firms in the pharmaceutical industry. Our main objective is to show …

It is proposed that developments in the commercialization of science and technology in" new
economy" sectors such as telecommunications, information technology and biotechnology …

This paper examines the patterns of technological innovation in Germany, and compares
them with those prevalent in the US and UK economies. The paper argues that the …

Recent policies to promote biotechnology are motors of broader R&D reform in Germany
and Japan. The idiosyncrasies of biotechnology commercialization could not be readily …

The concept of the National System of Innovation (NSI) has been applied in order to analyze
the interrelation of institutions and technological development. It has been diversified as a …

Innovating firms in new industries face a number of technological and market risks,
especially appropriability and competence destruction. However, the relative significance of …